申请人:The United States of America as represented by the Department of Health and Human Services
公开号:US06509344B1
公开(公告)日:2003-01-21
A number of indenoisoquinolines were prepared and evaluated for cytotoxicity in human cancer cell cultures and for activity versus topoisomerase I. The two most cytotoxic indenoisoquinolines proved to be cis-6-ethyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline and cis-6-allyl-5,6,12,13-tetrahydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-(11H)indeno[1,2-c]isoquinoline. Two of the most potent topoisomerase I inhibitors were 6-(3-carboxy-1-propyl)-5,6-dihydro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (26) and 6-ethyl-2,3-dimethoxy-8,9-(methylenedioxy)-11H-indeno[1,2-c]isoquinolinium chloride (27). Two additional potent topoisomerase I inhibitors, 6-allyl-5,6-dihydro-2,3-dimethoxy-8,9-(methylenedioxy)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline (13c) and 5,6-dihydro-6-(4-hydoxybut-1-yl)-2,3-dimethoxy-8,9-methylenedioxy-5,11 dioxo-(11H)-indeno[1,2-c]isoquinoline (19a), did not unwind DNA and did not affect topoisomerase II.
一些吲哚异喹啉被制备并在人类癌细胞培养物中评估其细胞毒性和对拓扑异构酶I的活性。最具细胞毒性的两种吲哚异喹啉被证明是顺式-6-乙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-11H-吲哚[1,2-c]异喹啉和顺式-6-烯丙基-5,6,12,13-四氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-(11H)吲哚[1,2-c]异喹啉。其中最有效的两种拓扑异构酶I抑制剂是6-(3-羧基-1-丙基)-5,6-二氢-5,11-二氧代-11H-吲哚[1,2-c]异喹啉(26)和6-乙基-2,3-二甲氧基-8,9-(亚甲二氧基)-11H-吲哚[1,2-c]异喹啉盐酸盐(27)。另外两种有效的拓扑异构酶I抑制剂,6-烯丙基-5,6-二氢-2,3-二甲氧基-8,9-(亚甲二氧基)-5,11-二氧代-11H-吲哚[1,2-c]异喹啉(13c)和5,6-二氢-6-(4-羟基丁-1-基)-2,3-二甲氧基-8,9-亚甲二氧基-5,11-二氧代-(11H)-吲哚[1,2-c]异喹啉(19a)未解开DNA,也未影响拓扑异构酶II。